<h1>Orchid Pharma Completes Amalgamation of Dhanuka Laboratories Limited</h1>
The Scheme of Amalgamation involving Orchid Pharma Limited and Dhanuka Laboratories Limited has become effective as of July 10, 2026. The amalgamation concludes with the dissolution of Dhanuka Laboratories Limited, which is now absorbed into Orchid Pharma Limited.
The process followed a National Company Law Tribunal order sanctioning the scheme. According to the terms of the Scheme, the Amalgamating Company (Dhanuka Laboratories Limited) has been fully integrated with the Amalgamated Company (Orchid Pharma Limited).
Upon the completion of the merger, Dhanuka Laboratories Limited stands dissolved without being wound up, and Orchid Pharma Limited now incorporates its operations following the stipulated process. The Appointed Date for this Scheme of Amalgamation was April 01, 2024.
Key details regarding the organizational restructuring are summarized below:
| Company | Role in Scheme | Status |
|---|---|---|
| Orchid Pharma Limited | Amalgamated Company (The ultimate entity) | Operational post-amalgamation |
| Dhanuka Laboratories Limited | Amalgamating Company | Dissolved without being wound up |
The Effective Date of the Scheme was confirmed as July 10, 2026.
ORCHPHARMA Stock Price Movement
Orchid Pharma Limited's shares closed lower today after shedding 4.09%, settling at ₹1012.55 in post-market trading. The stock saw a traded volume of 288,100 shares as it finished the day well below its opening price.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.